It was then studied in 2 neurological conditions such as myasthenia gravis and aquaporin-4 (Aqp-4) antibody positive neuromyelitis optica spectrum disorder (NMOSD), where complement involvement is seen but less well-delineated. This evidence concerns the gene AQP4 and neuromyelitis optica.